West Oak Capital LLC Has $110,000 Stock Holdings in Baxter International Inc. (NYSE:BAX)

West Oak Capital LLC increased its position in Baxter International Inc. (NYSE:BAX) by 345.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,785 shares of the medical instruments supplier’s stock after buying an additional 2,935 shares during the quarter. West Oak Capital LLC’s holdings in Baxter International were worth $110,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in the business. Bruce G. Allen Investments LLC increased its position in Baxter International by 247.3% in the 4th quarter. Bruce G. Allen Investments LLC now owns 2,622 shares of the medical instruments supplier’s stock valued at $76,000 after acquiring an additional 1,867 shares during the period. A. D. Beadell Investment Counsel Inc. bought a new stake in shares of Baxter International in the fourth quarter worth $294,000. PVG Asset Management Corp bought a new stake in shares of Baxter International in the third quarter worth $429,000. TD Private Client Wealth LLC increased its holdings in Baxter International by 29.5% in the third quarter. TD Private Client Wealth LLC now owns 41,027 shares of the medical instruments supplier’s stock valued at $1,558,000 after purchasing an additional 9,357 shares during the period. Finally, Toronto Dominion Bank raised its position in Baxter International by 15.4% during the 3rd quarter. Toronto Dominion Bank now owns 170,855 shares of the medical instruments supplier’s stock worth $6,487,000 after purchasing an additional 22,787 shares during the last quarter. Institutional investors own 90.19% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on BAX shares. StockNews.com downgraded shares of Baxter International from a “buy” rating to a “hold” rating in a research report on Monday, November 11th. Stifel Nicolaus reduced their price objective on shares of Baxter International from $46.00 to $38.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Finally, Citigroup lowered their target price on shares of Baxter International from $37.00 to $35.00 and set a “neutral” rating for the company in a research note on Wednesday, December 11th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, Baxter International currently has an average rating of “Hold” and an average target price of $40.45.

Baxter International Stock Down 0.6 %

Shares of NYSE:BAX traded down $0.18 during trading on Friday, reaching $29.41. 5,954,529 shares of the stock were exchanged, compared to its average volume of 4,254,838. Baxter International Inc. has a 1-year low of $28.33 and a 1-year high of $44.01. The stock has a fifty day moving average of $31.71 and a two-hundred day moving average of $34.83. The company has a debt-to-equity ratio of 1.31, a current ratio of 1.43 and a quick ratio of 1.09. The firm has a market cap of $15.02 billion, a price-to-earnings ratio of 147.06, a price-to-earnings-growth ratio of 12.74 and a beta of 0.59.

Baxter International (NYSE:BAX) last released its quarterly earnings data on Friday, November 8th. The medical instruments supplier reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.02. The firm had revenue of $3.85 billion for the quarter, compared to analyst estimates of $3.85 billion. Baxter International had a net margin of 0.77% and a return on equity of 18.30%. The business’s quarterly revenue was up 3.8% compared to the same quarter last year. During the same period last year, the firm earned $0.68 earnings per share. Research analysts anticipate that Baxter International Inc. will post 1.92 earnings per share for the current fiscal year.

Baxter International Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th were issued a $0.17 dividend. The ex-dividend date was Friday, November 29th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 2.31%. Baxter International’s dividend payout ratio is presently 340.00%.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.